TY - JOUR
T1 - The significance of HIV to bone mineral density
AU - Wessman, Maria
AU - Weis, Nina
AU - Katzenstein, Terese L.
AU - Lebech, Anne Mette
AU - Thorsteinsson, Kristina
AU - Hansen, Ann Brit Eg
AU - Jensen, Jens Erik Beck
PY - 2017/9/4
Y1 - 2017/9/4
N2 - The life expectancy in well-treated HIV-infected persons approaches that of the general population, but HIV-infected persons have a greater incidence of fractures and osteoporosis. A decrease in bone mineral density is observed primarily during the first 1-2 years of antiretroviral therapy. Dual X-ray absorptiometry scan should be considered in HIV-infected men ≥ 50 years and postmenopausal women. In case of osteoporosis, bisphosphonate treatment should follow guidelines for the general population. Future research should focus on pathogenesis and prevention of bone density loss in HIV.
AB - The life expectancy in well-treated HIV-infected persons approaches that of the general population, but HIV-infected persons have a greater incidence of fractures and osteoporosis. A decrease in bone mineral density is observed primarily during the first 1-2 years of antiretroviral therapy. Dual X-ray absorptiometry scan should be considered in HIV-infected men ≥ 50 years and postmenopausal women. In case of osteoporosis, bisphosphonate treatment should follow guidelines for the general population. Future research should focus on pathogenesis and prevention of bone density loss in HIV.
UR - http://www.scopus.com/inward/record.url?scp=85059797648&partnerID=8YFLogxK
M3 - Review
C2 - 28874254
AN - SCOPUS:85059797648
VL - 179
JO - Ugeskrift for Laeger
JF - Ugeskrift for Laeger
SN - 0041-5782
IS - 36
ER -